Dr Anne Peters, of the Keck School of Medicine of the University of Southern California, reports on the latest research on insulin therapy in adults with type 2 diabetes, presented at the European ...

HAMBURG, Germany -- Adding weekly tirzepatide (Mounjaro) to basal insulin reduced HbA1c in patients with poorly controlled type 2 diabetes compared with adding three-times-daily insulin lispro, the ...

Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?

(HealthDay News) — For patients with type 2 diabetes, the risk of acute myocardial infarction (AMI) is not significantly different for long-acting insulin analogs versus other basal insulin therapies, ...

Dexcom Smart Basal is FDA cleared and now the first and only CGM-integrated basal insulin dosing optimizer for adults aged 18 and older with Type 2 diabetes who are using long-acting insulin. Dexcom ...

New insulin products were the go-to choice for U.S. adults with type 2 diabetes in the last half decade, researchers reported. According to a serial cross-sectional study of ambulatory insulin use ...

Ethnicity & Disease, Vol. 27, No. 1, Cardiovascular Disease and Risk Factors (Winter 2017), pp. 45-54 (10 pages) Objective: To evaluate the effectiveness and safety of insulin detemir treatment as add ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with type 2 diabetes prescribed basal insulin ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

Dexcom Smart Basal is designed to make basal insulin initiation and management simpler and more personalized for users and their healthcare providers.* Dexcom Smart Basal is FDA cleared and now the ...